AI assistant
Sending…
Pediatrix Medical Group, Inc. — Director's Dealing 2021
May 14, 2021
31972_dirs_2021-05-14_47537679-9f2b-4ddd-b3d5-339794670196.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MEDNAX, INC. (MD)
CIK: 0000893949
Period of Report: 2021-05-12
Reporting Person: MEDEL ROGER MD (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-12 | Common Stock | A | 4885 | $0.00 | Acquired | 1322542 | Direct |
Footnotes
F1: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award. Shares will vest on May 12, 2022.
More from Pediatrix Medical Group, Inc.
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 17
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3